Vimarsana
Biggest News Aggregation in the World

Page 19 - Crispr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Crispr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Crispr Today - Breaking & Trending Today

Key Charpentier/Doudna CRISPR patent upheld by Japanese Patent Office - Vimarsana News

Key Charpentier/Doudna CRISPR patent upheld by Japanese Patent Office

Patent JP6692856 upheld for second time in response to invalidation challenge.

CAR T Therapy May Cause Rare Cancer & How CRISPR Could Be The Solution - Vimarsana News

CAR T Therapy May Cause Rare Cancer & How CRISPR Could Be The Solution

CAR T therapy safety falls into question as the FDA investigates reports of rare T cell lymphoma after treatment. This concern could be resolved with CRISPR technology.

Source: forbes.com
The Age of Crispr Medicine Is Here - Vimarsana News

The Age of Crispr Medicine Is Here

The approval of the first Crispr-based therapy is just the beginning. Getting it to patients is the next hurdle.

Source: wired.com
EU Conditional Approval: Gene Editor to Treat Blood Diseases - Vimarsana News

EU Conditional Approval: Gene Editor to Treat Blood Diseases

The single-dose therapy involves treating and editing patient stem cells ex vivo, then reinfusing them.

Sickle Cell CRISPR Therapy May Offer 'Functional Cure' - Vimarsana News

Sickle Cell CRISPR Therapy May Offer 'Functional Cure'

Patients with severe sickle cell disease could soon be freed from vaso-occlusive crises after receiving an infusion of exa-cel, the first gene-editing therapy to use CRISPR technology.